Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Hammersmith Campus, Imperial College London, London, UK.
European journal of clinical nutrition (Impact Factor: 2.95). 01/2011; 65(4):508-13. DOI: 10.1038/ejcn.2010.291
Source: PubMed

ABSTRACT The sweet-taste receptor (T1r2+T1r3) is expressed by enteroendocrine L-cells throughout the gastrointestinal tract. Application of sucralose (a non-calorific, non-metabolisable sweetener) to L-cells in vitro stimulates glucagon-like peptide (GLP)-1 secretion, an effect that is inhibited with co-administration of a T1r2+T1r3 inhibitor. We conducted a randomised, single-blinded, crossover study in eight healthy subjects to investigate whether oral ingestion of sucralose could stimulate L-cell-derived GLP-1 and peptide YY (PYY) release in vivo.
Fasted subjects were studied on 4 study days in random order. Subjects consumed 50 ml of either water, sucralose (0.083% w/v), a non-sweet, glucose-polymer matched for sweetness with sucralose addition (50% w/v maltodextrin+0.083% sucralose) or a modified sham-feeding protocol (MSF=oral stimulation) of sucralose (0.083% w/v). Appetite ratings and plasma GLP-1, PYY, insulin and glucose were measured at regular time points for 120 min. At 120 min, energy intake at a buffet meal was measured.
Sucralose ingestion did not increase plasma GLP-1 or PYY. MSF of sucralose did not elicit a cephalic phase response for insulin or GLP-1. Maltodextrin ingestion significantly increased insulin and glucose compared with water (P<0.001). Appetite ratings and energy intake were similar for all groups.
At this dose, oral ingestion of sucralose does not increase plasma GLP-1 or PYY concentrations and hence, does not reduce appetite in healthy subjects. Oral stimulation with sucralose had no effect on GLP-1, insulin or appetite.

Download full-text


Available from: Heather E Ford, Aug 21, 2014
1 Follower
    • "A direct effect of artificial sweeteners on incretin secretion has been shown in enteroendocrine cell lines and tissue explants/minced intestinal tissues (Margolskee et al., 2007). Although one human study reports altered plasma GLP-1 and PYY levels after co-ingestion of glucose and lactisole as a T1R2/3 inhibitor (Gerspach et al., 2011), in vivo studies in animals and humans failed to observe a direct effect of artificial sweeteners on incretin secretion (Ford et al., 2011; Wu et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Nutrient transporters are integral membrane proteins responsible for uptake into enterocytes and release of nutrients into circulation. Absorption of food breakdown products such as fatty acids, monosaccharides or amino acids requires high capacity transporters. In case of glucose, amino acids and peptides, the transporters are electrogenic in nature, coupling substrate flux to ion movement. Whereas glucose absorption is mediated by the Na(+) -dependent SGLT1 protein, uptake of short-chain peptides is mediated by the H(+) -coupled PEPT1 protein. Interestingly, both transporters were recently shown to fulfil an additional role as intestinal "sensors" in enteroendocrine cells, mediating the release of gastrointestinal peptide hormones into circulation. Sensing of D-glucose and of di- and tripeptides is particularly relevant for the secretion of the incretins GIP and GLP-1 that promote insulin output from ß-cells and mediate ß-cell protection. In addition to these sensing pathways, a variety of G-protein-coupled receptors are involved in sensing of intestinal contents. D-glucose is sensed not only by SGLT1 but also by the sweet-taste receptor T1R2/3 expressed in enteroendocrine cells. T1R2/3 activation increases SGLT1 levels and intestinal glucose absorption. Although T1R2/3 ligands such as artificial sweeteners were shown to elicit incretin secretion from enteroendocrine cell lines or in vitro in tissue preparations, convincing data that this is also relevant in vivo are missing to date. However, there is growing interest in targeting intestinal sensing pathways, involving receptors but also the "transceptors" PEPT1 and SGLT1, by use of drugs or food constituents to have the beneficial effects of incretins on pancreas and metabolic control. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Experimental physiology 07/2015; DOI:10.1113/EP085029 · 2.87 Impact Factor
  • Source
    • "The sweet receptor, T1R2+T1R3, and its signaling pathway in L cells have been shown to regulate oral glucose-stimulated GLP-1 secretion [14]. The applications of this finding in clinical trials have not been successful to date [15] [16] [17]. There is also evidence showing that the T2R bitter taste receptors are expressed in the enteroendocrine cells in gut and cell lines [18] [19] [20]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to examine the role of GLP-1 in the hypoglycemic activity of wild bitter gourd (Momordica charantia L., BG). In vitro, the GLP-1 secretion in STC-1, a murine enteroendocrine cell line, was dose dependently stimulated by water extract (WE), its fractions (WEL, >3 kD and WES, <3 kD), and a bitter compounds-rich fraction of BG. These stimulations were partially inhibited by probenecid, a bitter taste receptor inhibitor, and by U-73122, a phospholipase C β 2 inhibitor. These results suggested that the stimulation might involve, at least in part, certain bitter taste receptors and/or PLC β 2-signaling pathway. Two cucurbitane triterpenoids isolated from BG, 19-nor-cucurbita-5(10),6,8,22-(E),24-pentaen-3 β -ol, and 5 β ,19-epoxycucurbita-6,24-diene-3 β ,23 ξ -diol (karavilagenine E,) showed relative high efficacy in the stimulation. In vivo, mice fed BG diet showed higher insulinogenic index in an oral glucose tolerance test. A single oral dose of WE or WES pretreatment significantly improved intraperitoneal glucose tolerance. A single oral dose of WES significantly decreased glucose and increased insulin and GLP-1 in serum after 30 min. This acute hypoglycemic effect of WES was abolished by pretreatment with exendin-9, a GLP-1 receptor antagonist. Our data provide evidence that BG stimulates GLP-1 secretion which contributes, at least in part, to the antidiabetic activity of BG through an incretin effect.
    Evidence-based Complementary and Alternative Medicine 01/2013; 2013:625892. DOI:10.1155/2013/625892 · 1.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The city of Catania is one of the most seismically active areas of Italy. This paper describes and compares the results of in situ and laboratory investigations that were carried out in order to determine the dynamic characteristics of Saint Nicola alla Rena Church site. Special attention has been paid to the variation of shear modulus and damping ratio with strain level and depth. Moreover normalised laws are proposed to consider shear modulus decay and damping ratio increase with strain level. The deposits under consideration consist of fractured to slightly fractured lava, with horizons of scoriaceus lava, lava in blocks, “rifusa” and volcanoclastic rocks.
    Proceedings of the 15th International Conference on Soil Mechanics and Geotechnical Engineering, Satellite Conference “Lessons Learned from Recent Strong Earthquakes”, ISBN: 975-7180-06-8, Istanbul; 08/2001
Show more